search
Back to results

BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)

Primary Purpose

Traumatic Brain Injury

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
BETTER (Brain Injury, Education, Training, and Therapy to Enhance Recovery)
Usual Care
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Traumatic Brain Injury focused on measuring transitional care, patients, family caregivers

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Patients with TBI of any race/ethnicity, regardless of insurance status, will be eligible if they are/have: age 18 years or older; diagnosed with mild, moderate, or severe TBI [admission Glasgow Coma Scale score of 3-15]; admitted to a Duke University Hospital inpatient acute care unit; plans to be discharged directly home from Duke University Hospital without inpatient rehabilitation or transfer to other settings (community discharge); sufficient cognitive functioning to participate (i.e., able to follow 2-step commands), as determined by the Galveston Orientation and Amnesia Test (score >76 eligible); English- or Spanish-speaking (self-report); access to a phone or computer with internet capabilities for study participation Family members will include patient-identified biological relatives and friends and are eligible if they are/have: associated with a patient meets all above-listed patient criteria; age 18 years or older; an anticipated primary caregiver after discharge (i.e., plans to live in same home as patient or have direct contact with patient >10 hours/week); English- or Spanish-speaking (self-report); access to a phone or computer with internet capabilities for study participation. Patients with TBI will be excluded if they have/are: pre-injury cognitive impairments, early dementia, or Alzheimer's disease; acute, unstable neurologic condition(s); severe psychiatric diagnosis that are untreated with no psychiatric provider on record; admitted from settings or locations other than home; unable to identify a family member to participate with them in the study. Family members will be excluded if the associated patient is not eligible or declines participation.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    BETTER TBI (Traumatic Brain Injury) Transitional Care Intervention

    Usual Care

    Arm Description

    Skilled clinical interventionists follow a manualized intervention protocol to address patient/family needs; establish goals; coordinate post-hospital care, services, and resources; and provide patient/family education and training on self- and family-management and coping skills <16 weeks post-discharge.

    In alignment with U.S. usual care for patients with TBI (Traumatic Brain Injury), usual care arm activities for younger adults with TBI and their family caregivers will includes usual care discharge planning process and follow up (e.g., verbal and written discharge instructions, with guidance on medications, outpatient therapy, and follow-up appointments).

    Outcomes

    Primary Outcome Measures

    Change in SF-36 (36-item Short Form Survey) score
    The SF-36 is a quality of life (QOL) measurement with a score range of 0 to 100, where a higher score indicates a better outcome.

    Secondary Outcome Measures

    Change in Neuro-QOL, Cognitive functioning
    The Neuro-QOL is a self-report of health related quality of life for individuals with neurological disorders. Raw scores are converted to T-scores with a mean of 50 and standard deviation of 10.
    Change in Neuro-QOL, Upper & Lower extremity functioning
    The Neuro-QOL is a self-report of health related quality of life for individuals with neurological disorders. Raw scores are converted to T-scores with a mean of 50 and standard deviation of 10.
    Change in PHQ-9 (Patient Health Questionnaire-9)
    The PHQ-9 assesses degree of depression severity via questionnaire. It has a score range of 0 to 27, where a higher score indicates greater depression.
    Change in Self-Efficacy for Management of Chronic Conditions Scale
    The Self-Efficacy to Manage Chronic Disease Scale is made up of 6 items on a visual analog scale, ranging from 1 (not at all confident) to 10 (totally confident). The total score range is 6 to 60, where a higher score indicates greater confidence.
    Change in caregiver SF-36
    The SF-36 is a quality of life (QOL) measurement with a score range of 0 to 100, where a higher score indicates a better outcome.
    Number of participants utilizing transitional care
    Measured by patient and/or caregiver proxy report of patient transitional health care utilization.
    Change in Modified Caregiver Strain Index (MCSI)
    The MCSI can quickly screen for caregiver strain in long-term caregivers. Scoring is 2 points for each 'yes', 1 point for each 'sometimes', and 0 for each 'no' response. The total score ranges from 0 to 26, where a higher score indicates a higher level of caregiver strain.
    Change in Preparedness for Caregiving Scale
    The Preparedness for Caregiving Scale is a caregiver self-rated instrument that consists of eight items that asks caregivers how well prepared they believe they are for multiple domains of caregiving. Responses are rated on a 5 point scale with scores ranging from 0 (not at all prepared) to 4 (very well prepared). The scale is scored by calculating the mean of all items answered with a score range of 0 to 4. The higher the score the more prepared the caregiver feels for caregiving.
    Change in patient and caregiver quality of life / health status (Euro Qol, 5 Item [EQ-5D-5L])
    The EQ-5D-5L is a patient reported outcome consisting of 5 items asking about quality of life. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state.

    Full Information

    First Posted
    April 14, 2023
    Last Updated
    October 5, 2023
    Sponsor
    Duke University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05929833
    Brief Title
    BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)
    Official Title
    A Randomized Controlled Trial of BETTER, A Transitional Care Intervention, for Diverse Patients With Traumatic Brain Injury and Their Families
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    November 1, 2023 (Anticipated)
    Primary Completion Date
    March 31, 2027 (Anticipated)
    Study Completion Date
    March 31, 2028 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Duke University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Despite racial/ethnic disparities in outcomes for younger adults with traumatic brain injury (TBI), there are no U.S. standards for TBI transitional care for patients discharged home from acute hospital care. To enhance the standard of care, the investigators will examine the efficacy of the existing intervention named BETTER (Brain Injury, Education, Training, and Therapy to Enhance Recovery), a culturally-tailored, patient- and family-centered TBI transitional care intervention, compared to usual care, among younger adults with TBI and families. The knowledge generated will drive improvements in health equity for younger adults with TBI of various races/ethnicities and families, resulting in improved health of the public.
    Detailed Description
    Black and Latino younger adults (age 18-64) with mild-to-severe traumatic brain injury (TBI) face inequities in TBI-related consequences, demonstrated by higher incidence and hospitalization rates, and worse cognitive, physical, behavioral, and emotional impairments <12 months post-discharge compared to Whites. These impairments affect patients' abilities to independently manage their health, wellness, and activities of daily living, resulting in dependence on family, particularly for racial/ethnic minorities. The complexity of needs combined with the fragmentation of healthcare services creates the perfect storm for low patient quality of life (QOL), mismanaged symptoms, rehospitalizations, and increased caregiver strain. Lack of insurance or access to care, as well as language barriers, aggravate these ongoing issues. Despite complex health needs, there are no U.S. standards for transitional care for patients with TBI. Transitional care is defined as actions in the clinical encounter designed to ensure the coordination and continuity of healthcare for patients transferring between different locations or levels of care (e.g., acute hospital care to home). In other patient groups with acute events (e.g., stroke, myocardial infarction), transitional care interventions have led to improved patient QOL and health outcomes. Yet, few TBI transitional care interventions exist, and these existing interventions do not equitably address needs of racial/ethnic minorities. The prevailing racial/ethnic disparities in TBI outcomes and the paucity of theory-driven, evidence-based TBI transitional care interventions led the team to develop a culturally-tailored intervention named BETTER (Brain Injury, Education, Training, and Therapy to Enhance Recovery). Based on the Individual and Family Self-Management Theory (IFSMT), BETTER is a patient- and family-centered, behavioral intervention for younger adults with TBI discharged home from acute hospital care and families. The goal is to improve patients' QOL (change in SF-36 total score, primary outcome) by 16-weeks post-discharge, as this timeframe includes high rates of unmet patient/family needs and preventable clinical events. Skilled clinical interventionists follow a manualized intervention protocol to address patient/family needs; establish goals; coordinate post-hospital care, services, and resources; and provide patient/family education and training on self- and family-management and coping skills <16 weeks post-discharge. Findings from the NIH R03 pilot study showed BETTER significantly improved patients' physical QOL by 31.36 points (p = 0.006) and that the intervention was feasible and acceptable with younger adults with TBI and families. Thus, the purpose of this study is to examine the efficacy of BETTER (vs. usual care) among younger adults with TBI of various races/ethnicities who are discharged home from acute hospital care and families. Findings will guide the team in designing a future, multi-site trial to disseminate and implement BETTER into clinical practice to ultimately enhance the standard of care for younger adults with TBI and families. The new knowledge generated will drive advancements in health equity among younger adults with TBI of various races/ethnicities and families.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Traumatic Brain Injury
    Keywords
    transitional care, patients, family caregivers

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    500 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    BETTER TBI (Traumatic Brain Injury) Transitional Care Intervention
    Arm Type
    Experimental
    Arm Description
    Skilled clinical interventionists follow a manualized intervention protocol to address patient/family needs; establish goals; coordinate post-hospital care, services, and resources; and provide patient/family education and training on self- and family-management and coping skills <16 weeks post-discharge.
    Arm Title
    Usual Care
    Arm Type
    Placebo Comparator
    Arm Description
    In alignment with U.S. usual care for patients with TBI (Traumatic Brain Injury), usual care arm activities for younger adults with TBI and their family caregivers will includes usual care discharge planning process and follow up (e.g., verbal and written discharge instructions, with guidance on medications, outpatient therapy, and follow-up appointments).
    Intervention Type
    Behavioral
    Intervention Name(s)
    BETTER (Brain Injury, Education, Training, and Therapy to Enhance Recovery)
    Intervention Description
    The six components of BETTER include: 1) assessment of patient/family needs and referral to community-based resources; 2) patient goal setting and review of goals; 3) health care coordination; 4) availability of clinical interventionist to patient/family; 5) training on self- and family-management and brain injury coping skills; and 6) warm hand off/referral to the state-affiliated Brain Injury Association at the end of the intervention for additional resources.
    Intervention Type
    Other
    Intervention Name(s)
    Usual Care
    Intervention Description
    Usual care discharge planning process and follow up (e.g., verbal and written discharge instructions, with guidance on medications, outpatient therapy, and follow-up appointments)
    Primary Outcome Measure Information:
    Title
    Change in SF-36 (36-item Short Form Survey) score
    Description
    The SF-36 is a quality of life (QOL) measurement with a score range of 0 to 100, where a higher score indicates a better outcome.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Secondary Outcome Measure Information:
    Title
    Change in Neuro-QOL, Cognitive functioning
    Description
    The Neuro-QOL is a self-report of health related quality of life for individuals with neurological disorders. Raw scores are converted to T-scores with a mean of 50 and standard deviation of 10.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Change in Neuro-QOL, Upper & Lower extremity functioning
    Description
    The Neuro-QOL is a self-report of health related quality of life for individuals with neurological disorders. Raw scores are converted to T-scores with a mean of 50 and standard deviation of 10.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Change in PHQ-9 (Patient Health Questionnaire-9)
    Description
    The PHQ-9 assesses degree of depression severity via questionnaire. It has a score range of 0 to 27, where a higher score indicates greater depression.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Change in Self-Efficacy for Management of Chronic Conditions Scale
    Description
    The Self-Efficacy to Manage Chronic Disease Scale is made up of 6 items on a visual analog scale, ranging from 1 (not at all confident) to 10 (totally confident). The total score range is 6 to 60, where a higher score indicates greater confidence.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Change in caregiver SF-36
    Description
    The SF-36 is a quality of life (QOL) measurement with a score range of 0 to 100, where a higher score indicates a better outcome.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Number of participants utilizing transitional care
    Description
    Measured by patient and/or caregiver proxy report of patient transitional health care utilization.
    Time Frame
    16 weeks post-discharge
    Title
    Change in Modified Caregiver Strain Index (MCSI)
    Description
    The MCSI can quickly screen for caregiver strain in long-term caregivers. Scoring is 2 points for each 'yes', 1 point for each 'sometimes', and 0 for each 'no' response. The total score ranges from 0 to 26, where a higher score indicates a higher level of caregiver strain.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Change in Preparedness for Caregiving Scale
    Description
    The Preparedness for Caregiving Scale is a caregiver self-rated instrument that consists of eight items that asks caregivers how well prepared they believe they are for multiple domains of caregiving. Responses are rated on a 5 point scale with scores ranging from 0 (not at all prepared) to 4 (very well prepared). The scale is scored by calculating the mean of all items answered with a score range of 0 to 4. The higher the score the more prepared the caregiver feels for caregiving.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
    Title
    Change in patient and caregiver quality of life / health status (Euro Qol, 5 Item [EQ-5D-5L])
    Description
    The EQ-5D-5L is a patient reported outcome consisting of 5 items asking about quality of life. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state.
    Time Frame
    baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Patients with TBI of any race/ethnicity, regardless of insurance status, will be eligible if they are/have: age 18 years or older; diagnosed with mild, moderate, or severe TBI [admission Glasgow Coma Scale score of 3-15]; admitted to a Duke University Hospital inpatient acute care unit; plans to be discharged directly home from Duke University Hospital without inpatient rehabilitation or transfer to other settings (community discharge); sufficient cognitive functioning to participate (i.e., able to follow 2-step commands), as determined by the Galveston Orientation and Amnesia Test (score >76 eligible); English- or Spanish-speaking (self-report); access to a phone or computer with internet capabilities for study participation Family members will include patient-identified biological relatives and friends and are eligible if they are/have: associated with a patient meets all above-listed patient criteria; age 18 years or older; an anticipated primary caregiver after discharge (i.e., plans to live in same home as patient or have direct contact with patient >10 hours/week); English- or Spanish-speaking (self-report); access to a phone or computer with internet capabilities for study participation. Patients with TBI will be excluded if they have/are: pre-injury cognitive impairments, early dementia, or Alzheimer's disease; acute, unstable neurologic condition(s); severe psychiatric diagnosis that are untreated with no psychiatric provider on record; admitted from settings or locations other than home; unable to identify a family member to participate with them in the study. Family members will be excluded if the associated patient is not eligible or declines participation.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Tolu O Oyesanya, PhD, RN
    Phone
    919-684-5292
    Email
    tolu.oyesanya@duke.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Tolu O Oyesanya, PhD, Rn
    Organizational Affiliation
    Duke University School of Nursing
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    The proposed research will involve a sample of approximately N=500 individuals recruited from Duke University Hospital, located in Durham, NC. The final dataset will include self-reported demographic data, data collection measures, information recorded from study interventionists, and qualitative interview data (audio recordings and transcripts). We will be collecting identifying information. Although the final dataset will be de-identified, we believe there remains the possibility of deductive disclosure of participants with unusual characteristics. Thus, we will make data and associated documentation available to users only under a data-sharing agreement that provides for a commitment to: 1) using de-identified data only for research purposes and not to identify any individual participant; 2) securing the data using appropriate computer technology; and 3) destroying or returning the data after analyses are completed.

    Learn more about this trial

    BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)

    We'll reach out to this number within 24 hrs